Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed) iota | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0023 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.5 | 0.5 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0023 | 0.5 | 0.5 |
Echinococcus granulosus | dna polymerase eta | 0.0023 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.5 | 0.5 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0023 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.5 | 0.5 |
Echinococcus multilocularis | dna polymerase kappa | 0.0023 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.5 | 0.5 |
Echinococcus granulosus | dna polymerase kappa | 0.0023 | 0.5 | 0.5 |
Echinococcus multilocularis | dna polymerase eta | 0.0023 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0023 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.5 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.5 | 0.5 |
Leishmania major | DNA polymerase kappa, putative | 0.0023 | 0.5 | 0.5 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.5 | 0.5 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.5 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.5 | 0.5 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0023 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.5 | 0.5 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0023 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.5 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.5 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.5 | 0.5 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0023 | 0.5 | 0.5 |
Schistosoma mansoni | DNA polymerase eta | 0.0023 | 0.5 | 0.5 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0023 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0023 | 0.5 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.5 | 0.5 |
Trypanosoma brucei | unspecified product | 0.0023 | 0.5 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.5 | 0.5 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0023 | 0.5 | 0.5 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.5 | 0.5 |
Leishmania major | DNA polymerase eta, putative | 0.0023 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.5 | 0.5 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0023 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.4125 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.0795 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 8.2753 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.